ChemoCentryx Prices 5M Share Offering at $12.00/Share

ChemoCentryx

announced today that it has priced an underwritten public offering of an aggregate of 5,000,000 shares of its common stock at a price to the public of $12.00 per share.  In addition, ChemoCentryx has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock on the same terms and conditions to cover over-allotments, if any.  All shares of common stock to be sold in the offering will be offered by ChemoCentryx. The offering is expected to close on April 22, 2013, subject to customary closing conditions. J. P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering, and Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated are acting as co-managers for the offering. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on April 3, 2013. This offering is being made only by means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained from J. P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717